← Companies|Sihuan Pharma
46

Sihuan Pharma

460.HK·HKEXBeijing CNFounded 20014,000 employees
Small CappharmaPublicCNSCardiology
Platform: CNS Spec
Market Cap
$1B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (460.HK)
Loading 460.HK stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
460-4909460-4909Preclinical2mRNAPSMAUSP1iPAHGA
Sotobrutinib460-3713NDA/BLA2Cell TherapyBTKSTINGagCFFTD
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Sihuan Pharma trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)
2026-03-16
460-4909 Interim
PAH
Past
2029-03-10
Sotobrutinib Ph3 Readout
FTD
Ph3 Readout
2031-02-22
Sotobrutinib Ph3 Readout
CF
Ph3 Readout